Your browser doesn't support javascript.
loading
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
Lapitz, Ainhoa; Arbelaiz, Ander; O'Rourke, Colm J; Lavin, Jose L; Casta, Adelaida La; Ibarra, Cesar; Jimeno, Juan P; Santos-Laso, Alvaro; Izquierdo-Sanchez, Laura; Krawczyk, Marcin; Perugorria, Maria J; Jimenez-Aguero, Raul; Sanchez-Campos, Alberto; Riaño, Ioana; Gónzalez, Esperanza; Lammert, Frank; Marzioni, Marco; Macias, Rocio I R; Marin, Jose J G; Karlsen, Tom H; Bujanda, Luis; Falcón-Pérez, Juan M; Andersen, Jesper B; Aransay, Ana M; Rodrigues, Pedro M; Banales, Jesus M.
Afiliación
  • Lapitz A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Arbelaiz A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • O'Rourke CJ; Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, 2200, Copenhagen, Denmark.
  • Lavin JL; CIC bioGUNE, Genome Analysis Platform, 48160, Derio, Spain.
  • Casta A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Ibarra C; Hospital of Cruces, 48903, Bilbao, Spain.
  • Jimeno JP; "Complejo Hospitalario de Navarra", 31008, Pamplona, Spain.
  • Santos-Laso A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Izquierdo-Sanchez L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Krawczyk M; Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), 28220, Madrid, Spain.
  • Perugorria MJ; Department of Medicine II, Saarland University Medical Centre, Saarland University, 66421, Homburg, Germany.
  • Jimenez-Aguero R; Laboratory of Metabolic Liver Diseases, Centre for Preclinical Research, Department of General, Transplant and Liver Surgery, 02-091, Warsaw, Poland.
  • Sanchez-Campos A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Riaño I; Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), 28220, Madrid, Spain.
  • Gónzalez E; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Lammert F; Hospital of Cruces, 48903, Bilbao, Spain.
  • Marzioni M; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
  • Macias RIR; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Exosomes Laboratory, 48160, Derio, Spain.
  • Marin JJG; Department of Medicine II, Saarland University Medical Centre, Saarland University, 66421, Homburg, Germany.
  • Karlsen TH; "Università Politecnica delle Marche", Department of Gastroenterology, 60121, Ancona, Italy.
  • Bujanda L; Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), 28220, Madrid, Spain.
  • Falcón-Pérez JM; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), 37007, Salamanca, Spain.
  • Andersen JB; Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), 28220, Madrid, Spain.
  • Aransay AM; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), 37007, Salamanca, Spain.
  • Rodrigues PM; Norwegian PSC Research Center, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, 0372, Oslo, Spain.
  • Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014, San Sebastian, Spain.
Cells ; 9(3)2020 03 14.
Article en En | MEDLINE | ID: mdl-32183400
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN / Biomarcadores / Colangiocarcinoma / Vesículas Extracelulares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Cells Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN / Biomarcadores / Colangiocarcinoma / Vesículas Extracelulares Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Cells Año: 2020 Tipo del documento: Article País de afiliación: España